Loading
Latest filing published 20 Jan 2022 for Lexston Life Sciences Corp., €3,523.
No signal scores available.
All filings by Jatinder Manhas on record concern Lexston Life Sciences Corp. We count 2 filings; the first trade dates from 17 June 2021 and the latest from 20 January 2022.
The open-market record is one-sided, with 1 purchase worth €3,523 and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2022 to date brings 1 purchase and no sales.
The newest entry dates from 20 January 2022: an open-market purchase of €3,523, in Lexston Life Sciences Corp. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations